TIP Chemotherapy for Metastatic Germ Cell Cancer
Author Information
Author(s): Mead G M, Cullen M H, Huddart R, Harper P, Rustin G J S, Cook P A, Stenning S P, Mason M
Primary Institution: Medical Research Council Clinical Trials Unit
Hypothesis
Can TIP chemotherapy effectively salvage patients with metastatic germ cell cancer who have failed initial BEP chemotherapy?
Conclusion
TIP chemotherapy can cure a substantial proportion of patients with metastatic germ cell cancer, particularly those with good prognosis.
Supporting Evidence
- Eight patients achieved complete remission and 18 achieved partial remission.
- The overall favorable response rate was 60%.
- Survival at 1 year was 70%.
Takeaway
This study tested a special medicine called TIP on patients with a type of cancer that didn't get better with the first treatment. Many patients got better after using TIP.
Methodology
Patients received four courses of TIP chemotherapy at 3-weekly intervals, and their responses were assessed based on tumor marker levels and imaging.
Potential Biases
Potential biases may arise from the multi-center nature of the study and variations in treatment administration.
Limitations
The study had a small sample size and results may not be generalizable to all patients with metastatic germ cell cancer.
Participant Demographics
The study included 51 male patients aged 16-65, primarily with nonseminoma histology.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI (44–75%)
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website